Vanessa Roldan Schilling-rekin lankidetzan egindako argitalpenak (7)

2023

  1. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making

    American Heart Journal, Vol. 258, pp. 1-16

2021

  1. Gut microbiota and the quality of oral anticoagulation in vitamin K antagonists users: A review of potential implications

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-16

2018

  1. Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated “Real-World” in Patients With Atrial Fibrillation

    American Journal of Cardiology, Vol. 122, Núm. 5, pp. 785-792

  2. Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality

    Cardiology Journal

2015

  1. Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 68, Núm. 6, pp. 497-504

  2. Effects of body mass index on the lipid profile and biomarkers of inflammation and a fibrinolytic and Prothrombotic state

    Journal of Atherosclerosis and Thrombosis, Vol. 22, Núm. 6, pp. 610-617

2013

  1. Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation

    PACE - Pacing and Clinical Electrophysiology, Vol. 36, Núm. 1, pp. 31-36